	Predicting Chemoresistance in HER2-low Breast Cancer: Histologic Grade, MRI Non-mass Enhancement, and Clinical T Stage. Anticancer Res Fuse Y, Fushimi A, Nameki A, Kawase K, Nogi H. PMID: 42823184 [PubMed - indexed for MEDLINE]
	Impact of Resection Margin Width on Local Control and Prognostic Factors in HER2-enriched and Triple-negative Breast Cancer in the Modern Systemic Treatment Era. Anticancer Res Chang WI, Jang BS, Chang JH, Kim K, Shin KH. PMID: 42823150 [PubMed - indexed for MEDLINE]
	Malignant phyllodes tumour with spinal metastasis presenting as cauda equina syndrome. BMJ Case Rep Mahboob O, Suk Y, Bishara M, Moammer G. PMID: 42823141 [PubMed - indexed for MEDLINE]
	First-trimester pregnancy-associated breast cancer managed without pregnancy termination: a report with long-term follow-up. BMJ Case Rep Vorapreechapanich A, Uerpairojkit B, Vongsaisuwon M. PMID: 42823140 [PubMed - indexed for MEDLINE]
	Optimizing Musculoskeletal Health in Breast Cancer Patients. Phys Med Rehabil Clin N Am Marshall G, Qin E. PMID: 42823033 [PubMed - indexed for MEDLINE]
	Treatment of Breast Cancer. Mayo Clin Proc Ruddy KJ, Idossa D, Black DM, Corbin KS, Cathcart-Rake E, O'Sullivan CC. PMID: 42822987 [PubMed - indexed for MEDLINE]
	A dual-tower multimodal framework with feature quality enhancement for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer: a multicenter study. Transl Oncol Ke Y, Yang W, Yang Z, Yue J, Li C, Yuan P, Yang J. PMID: 42822322 [PubMed - as supplied by publisher]
	Cost-Effectiveness of AI in Breast Cancer Screening and Lung Cancer Diagnostics: A Case Study From Costa Rica. Value Health Reg Issues Aboa LK, Segura Aparicio JC, Fei ZY, Tyrrell PN. PMID: 42822279 [PubMed - as supplied by publisher]
	Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study. Breast Noguchi N, Ormiston-Smith N, Marinovich ML, Moore J, Houssami N. PMID: 42822240 [PubMed - as supplied by publisher]
	Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer. Gynecol Oncol Smith G, Petty A, Krivanek K, Rose PG. PMID: 42822082 [PubMed - as supplied by publisher]
	Real-world treatment patterns, healthcare resource utilization, and costs associated with high-risk endometrial cancer in England: a retrospective cohort study. J Med Econ Ralphs E, Prabhu VS, Landfeldt E, Ridsdale-Smith J, Teoh C, Macey K, Trankov N, Lambova A, Lichfield J, Eminowicz G. PMID: 42821774 [PubMed - indexed for MEDLINE]
	Screening for Common Gynecologic Malignancies. Radiographics Jha P, Nougaret S, Iranpour N, Lakhman Y, Venkatesan AM. PMID: 42821448 [PubMed - indexed for MEDLINE]
	Platelet activation and eicosanoid signaling in ovarian cancer: implications for biomarker development. Mol Biol Rep Kirmu, Jó, Kramkowski K. PMID: 42821018 [PubMed - indexed for MEDLINE]
	Disclosure, social support, and meaning-based coping among Omani mothers living with breast cancer: a phenomenological qualitative study. Support Care Cancer Al-Alawi KS, Al Sumri HH, Al Fahdi AS, Chan MF, Al Kayoumi ZT, Al-Azri M. PMID: 42820992 [PubMed - indexed for MEDLINE]
	The development of juntas contra el virus del papiloma humano: An HPV self-sampling intervention for underscreened Latinas. Womens Health (Lond) Martínez O, Cora-Cruz M, Perez S, French A, Gerena AC, Fang C. PMID: 42820943 [PubMed - indexed for MEDLINE]
	Evaluation of serum soluble triggering receptor expressed on myeloid cells-1 in polycystic ovary syndrome. Rev Assoc Med Bras (1992) Onat T, Duz SA, Saridogan E, Gunal S, Senocak GNC, Tuncay G, Karaer A. PMID: 42820575 [PubMed - indexed for MEDLINE]
	Lower-Cost Nonsurgical Primary Prevention Strategies for Women at High Risk of Breast Cancer: A Scoping Review. Breast J Wen M, Zhao Y, He C. PMID: 42820352 [PubMed - indexed for MEDLINE]
	Antibody-drug conjugates in breast cancer: redefining targeted therapy. J Clin Invest Guo C, Ellisen LW. PMID: 42820303 [PubMed - indexed for MEDLINE]
	Toward targeted therapeutics for lobular breast cancer. J Clin Invest Fanucci KA, Bahnassy S, Roy AM, Sokolova A, Stover DG, Simpson PT, Riggins RB, Jeselsohn R. PMID: 42820289 [PubMed - indexed for MEDLINE]
	Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions. J Clin Invest Walmsley CS, Rodriguez A, Konstantinopoulos PA, Shapiro GI, Tolaney SM, Garber JE, Lynce F. PMID: 42820288 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335941

Page 1 of 16798



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy